156 related articles for article (PubMed ID: 35667297)
1. Evaluation of pathological complete response after neoadjuvant systemic treatment of invasive breast cancer using diffusion-weighted imaging compared with dynamic contrast-enhanced based kinetic analysis.
Ota R; Kataoka M; Iima M; Honda M; Ohashi A; Ohno Kishimoto A; Miyake KK; Yamada Y; Takeuchi Y; Toi M; Nakamoto Y
Eur J Radiol; 2022 Sep; 154():110372. PubMed ID: 35667297
[TBL] [Abstract][Full Text] [Related]
2. High-resolution diffusion-weighted imaging compared with conventional diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging with regard to image quality and assessment of breast cancer morphology.
Metin Y; Orhan Metin N; Kul S; Taşçı F; Özdemir O; Küpeli A
Diagn Interv Radiol; 2023 Mar; 29(2):251-259. PubMed ID: 36987843
[TBL] [Abstract][Full Text] [Related]
3. The assessment of pathological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer patients with DCE-MRI and DWI: a systematic review and meta-analysis.
Zong R; Ma X; Shi Y; Geng L
Br J Radiol; 2023 Oct; 96(1150):20230239. PubMed ID: 37660472
[TBL] [Abstract][Full Text] [Related]
4. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
[TBL] [Abstract][Full Text] [Related]
5. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
6. Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT.
An YY; Kim SH; Kang BJ; Lee AW
J Korean Med Sci; 2015 Jun; 30(6):808-15. PubMed ID: 26028936
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
Li X; Abramson RG; Arlinghaus LR; Kang H; Chakravarthy AB; Abramson VG; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Grau AM; Sanders M; Yankeelov TE
Invest Radiol; 2015 Apr; 50(4):195-204. PubMed ID: 25360603
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted imaging or dynamic contrast-enhanced curve: a retrospective analysis of contrast-enhanced magnetic resonance imaging-based differential diagnoses of benign and malignant breast lesions.
Yang X; Dong M; Li S; Chai R; Zhang Z; Li N; Zhang L
Eur Radiol; 2020 Sep; 30(9):4795-4805. PubMed ID: 32350660
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic performance of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in evaluating the pathological response of breast cancer to neoadjuvant chemotherapy: A meta-analysis.
Li Z; Li J; Lu X; Qu M; Tian J; Lei J
Eur J Radiol; 2021 Oct; 143():109931. PubMed ID: 34492627
[TBL] [Abstract][Full Text] [Related]
11. Potential of Noncontrast Magnetic Resonance Imaging With Diffusion-Weighted Imaging in Characterization of Breast Lesions: Intraindividual Comparison With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Baltzer PAT; Bickel H; Spick C; Wengert G; Woitek R; Kapetas P; Clauser P; Helbich TH; Pinker K
Invest Radiol; 2018 Apr; 53(4):229-235. PubMed ID: 29190227
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
[TBL] [Abstract][Full Text] [Related]
13. MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report.
Petrillo M; Fusco R; Catalano O; Sansone M; Avallone A; Delrio P; Pecori B; Tatangelo F; Petrillo A
Biomed Res Int; 2015; 2015():514740. PubMed ID: 26413528
[TBL] [Abstract][Full Text] [Related]
14. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
[TBL] [Abstract][Full Text] [Related]
16. Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer.
Park SH; Moon WK; Cho N; Chang JM; Im SA; Park IA; Kang KW; Han W; Noh DY
Eur Radiol; 2012 Jan; 22(1):18-25. PubMed ID: 21845462
[TBL] [Abstract][Full Text] [Related]
17. Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrast-enhanced MRI to improve accuracy of the differential diagnosis of benign and malignant breast lesions.
Ma D; Lu F; Zou X; Zhang H; Li Y; Zhang L; Chen L; Qin D; Wang B
Magn Reson Imaging; 2017 Feb; 36():175-179. PubMed ID: 27742437
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC).
Abdelhafez AH; Musall BC; Adrada BE; Hess K; Son JB; Hwang KP; Candelaria RP; Santiago L; Whitman GJ; Le-Petross HT; Moseley TW; Arribas E; Lane DL; Scoggins ME; Leung JWT; Mahmoud HS; White JB; Ravenberg EE; Litton JK; Valero V; Wei P; Thompson AM; Moulder SL; Pagel MD; Ma J; Yang WT; Rauch GM
Breast Cancer Res Treat; 2021 Jan; 185(1):1-12. PubMed ID: 32920733
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and Diagnostic Performance of Voxelwise Computed Diffusion-Weighted Imaging in Breast Cancer.
Zhou J; Chen E; Xu H; Ye Q; Li J; Ye S; Cheng Q; Zhao L; Su MY; Wang M
J Magn Reson Imaging; 2019 Jun; 49(6):1610-1616. PubMed ID: 30328211
[TBL] [Abstract][Full Text] [Related]
20. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.
Avendano D; Marino MA; Leithner D; Thakur S; Bernard-Davila B; Martinez DF; Helbich TH; Morris EA; Jochelson MS; Baltzer PAT; Clauser P; Kapetas P; Pinker K
Breast Cancer Res; 2019 Dec; 21(1):136. PubMed ID: 31801635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
